Ligand validation:9KUK

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9KUK_LFA_P_314	30%	86%	0.19	0.896	0.46	0.26	-	-	3	0	75%	0.6
9KUK_LFA_P_310	26%	94%	0.227	0.885	0.23	0.2	-	-	3	0	90%	0.4
9KUK_LFA_N_609	22%	89%	0.235	0.905	0.23	0.39	-	-	4	0	70%	0.6
9KUK_LFA_P_315	20%	93%	0.224	0.892	0.21	0.27	-	-	1	0	65%	0.6
9KUK_LFA_A_608	20%	89%	0.234	0.891	0.46	0.2	-	-	3	0	70%	0.6
9KUK_LFA_C_309	19%	93%	0.235	0.849	0.22	0.27	-	-	0	0	90%	0.4
9KUK_LFA_G_105	17%	71%	0.246	0.88	0.73	0.41	-	-	7	0	70%	0.6
9KUK_LFA_C_313	16%	87%	0.256	0.868	0.28	0.41	-	-	1	0	75%	0.6
9KUK_LFA_B_308	16%	91%	0.276	0.87	0.4	0.18	-	-	1	0	85%	0.6
9KUK_LFA_A_609	15%	66%	0.249	0.863	0.77	0.56	-	-	6	0	70%	0.6
9KUK_LFA_N_601	15%	90%	0.272	0.858	0.32	0.28	-	-	1	0	85%	0.6
9KUK_LFA_T_102	14%	96%	0.267	0.897	0.22	0.16	-	-	0	0	55%	0.6
9KUK_LFA_C_310	10%	96%	0.287	0.87	0.23	0.15	-	-	0	0	55%	0.5
9KUK_LFA_C_314	10%	94%	0.287	0.849	0.22	0.22	-	-	1	0	65%	0.6
9KUK_LFA_P_308	9%	97%	0.297	0.876	0.18	0.14	-	-	1	0	55%	0.4
9KUK_LFA_C_307	9%	95%	0.292	0.87	0.24	0.18	-	-	3	0	55%	0.4
9KUK_LFA_P_301	9%	98%	0.308	0.844	0.14	0.13	-	-	0	0	75%	0.4
9KUK_LFA_P_312	8%	98%	0.317	0.848	0.15	0.12	-	-	0	0	70%	0.5
9KUK_LFA_O_301	7%	94%	0.308	0.852	0.28	0.18	-	-	2	0	55%	0.6
9KUK_LFA_P_313	7%	93%	0.301	0.844	0.25	0.23	-	-	1	0	55%	0.5
9KUK_LFA_C_325	7%	99%	0.34	0.843	0.16	0.08	-	-	0	0	75%	0.4
9KUK_LFA_C_312	6%	92%	0.334	0.857	0.25	0.26	-	-	2	0	55%	0.5
9KUK_LFA_C_311	6%	96%	0.338	0.833	0.19	0.15	-	-	0	0	70%	0.5
9KUK_LFA_P_309	3%	96%	0.351	0.834	0.29	0.08	-	-	0	0	30%	0.4
9KUK_LFA_C_308	3%	98%	0.357	0.815	0.21	0.07	-	-	0	0	30%	0.4
9KUK_LFA_P_311	1%	99%	0.411	0.725	0.13	0.09	-	-	0	0	55%	0.5
9IKI_LFA_N_608	41%	91%	0.169	0.937	0.29	0.29	-	-	5	0	70%	0.6
9IKG_LFA_P_313	33%	92%	0.187	0.912	0.27	0.24	-	-	0	0	75%	0.6
9KUM_LFA_P_313	32%	90%	0.187	0.908	0.38	0.22	-	-	1	0	75%	0.6
8H8R_LFA_C_309	31%	95%	0.194	0.878	0.22	0.19	-	-	10	0	90%	0.4
9IKH_LFA_N_609	29%	86%	0.203	0.915	0.33	0.38	-	-	6	0	70%	0.6
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
6SU3_LFA_X_301	65%	96%	0.071	0.945	0.18	0.18	-	-	0	0	60%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	7	0	75%	1
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	1
8R98_LFA_A_401	55%	100%	0.089	0.937	0.09	0.08	-	-	0	0	55%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.